Page last updated: 2024-09-03

caprylates and Allergic Encephalomyelitis

caprylates has been researched along with Allergic Encephalomyelitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Amadio, S; Camponeschi, C; Clementi, ME; De Carluccio, M; Di Liddo, R; Di Sante, G; Michetti, F; Ria, F; Romano Spica, V; Sampaolese, B; Tredicine, M; Volonté, C	1

Other Studies

1 other study(ies) available for caprylates and Allergic Encephalomyelitis

Article	Year
S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis. International journal of molecular sciences, 2021, Dec-17, Volume: 22, Issue:24 Topics: Animals; Caprylates; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Multiple Sclerosis; S100 Calcium Binding Protein beta Subunit	2021

Article

Year

S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis.

International journal of molecular sciences, 2021, Dec-17, Volume: 22, Issue:24

Topics: Animals; Caprylates; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Multiple Sclerosis; S100 Calcium Binding Protein beta Subunit

2021